Back to search

Article

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

2009-01-01

Abstract

Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.

Full abstract shown under CC BY

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8af681cb-1c96-5c02-b4ab-94682af74e63
DOI
10.1186/1744-859x-8-15
PMCID
PMC2705371
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness studyDOI 10.1186/1744-859x-8-15
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studySemantic proximity
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studySemantic proximity
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in SwitzerlandSemantic proximity
Understanding the direct and indirect costs of patients with schizophreniaSemantic proximity
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selectionSemantic proximity
The Global Economic Burden of Schizophrenia: An Umbrella Review of Systematic Reviews and Meta-AnalysesSemantic proximity
“The Efficacy and Safety of Aripiprazole and Paliperidone 1 and 3-Month Long-Acting Preparations During The Maintenance of Schizophrenia in Clinical Practice”Semantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoverySemantic proximity
Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension StudiesSemantic proximity
Prevalence and associated factors of Tardive dyskinesia among psychiatric patients on first-generation antipsychotics at Jimma University specialized hospital, psychiatric clinic, Ethiopia: Institution based a cross-sectional studySemantic proximity
Factors associated with extrapyramidal side effects of first-generation antipsychotics: a cross- sectional study in Ugandan tertiary hospitalsSemantic proximity
Select a neighboring publication to make it the new centre.